APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Vaccine

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.

Selected research

Industry Growth & Trends

Global Veterinary Vaccine Industry Growth and Trends Forecast to 2032

8 January 2026125 pages

Choose your research edition.

Industry ResearchVeterinary Vaccine Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Vaccine Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Veterinary Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Vaccine Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Vaccine Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.

Global Veterinary Vaccine key players include Merck, Boehringer Ingelheim, Zoetis, Ceva, Elanco, etc. Global top five manufacturers hold a share about 75%. North America and Asia Pacific is the largest market, both with a share about 30%, followed by Europe, with a share about 25 percent. In terms of product, Live Attenuated Vaccines is the largest segment, with a share about 60%. And in terms of application, the largest application is Dog & Cat, followed by Livestock, Swine, Chicken, etc.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Veterinary Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Veterinary Vaccine market size, estimates, and forecasts are presented in terms of sales volume (M Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Veterinary Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Veterinary Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Veterinary Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Veterinary Vaccine Market by Company

Merck

Zoetis

Boehringer Ingelheim

Ceva

CAHIC

HVRI

Ringpu Biology

Yebio

DHN

WINSUN

Elanco

Virbac

Jinyu Bio-Technology

ChengDu Tecbond

CAVAC

Kyoto Biken Laboratories

FATRO

Vaksindo

Bio-Labs

Avimex Animal Health

MEVAC

Biovac

Atafen

Dyntec

BioTestLab

RVSRI

Medion

Veterinary Vaccine Segment by Type

Live Attenuated Vaccines

Inactivated Vaccines

Others

Veterinary Vaccine Segment by Application

Livestock

Swine

Chicken

Dog & Cat

Others

Veterinary Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Veterinary Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Live Attenuated Vaccines Table 2. Major Company of Inactivated Vaccines Table 3. Major Company of Others Table 4. Global Veterinary Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Veterinary Vaccine Sales by Type (2021-2026) & (M Doses) Table 6. Global Veterinary Vaccine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Veterinary Vaccine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Veterinary Vaccine Sales Market Share in Value by Type (2021-2026) Table 9. Global Veterinary Vaccine Price by Type (2021-2026) & (USD/Doses) Table 10. Global Veterinary Vaccine Sales by Type (2027-2032) & (M Doses) Table 11. Global Veterinary Vaccine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Veterinary Vaccine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Veterinary Vaccine Sales Market Share in Value by Type (2027-2032) Table 14. Global Veterinary Vaccine Price by Type (2027-2032) & (USD/Doses) Table 15. North America Veterinary Vaccine Sales by Type (2021-2026) & (M Doses) Table 16. North America Veterinary Vaccine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Veterinary Vaccine Sales by Type (2021-2026) & (M Doses) Table 18. Europe Veterinary Vaccine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Veterinary Vaccine Sales by Type (2021-2026) & (M Doses) Table 20. Asia-Pacific Veterinary Vaccine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Veterinary Vaccine Sales by Type (2021-2026) & (M Doses) Table 22. Latin America Veterinary Vaccine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Veterinary Vaccine Sales by Type (2021-2026) & (M Doses) Table 24. Middle East and Africa Veterinary Vaccine Sales by Type (2021-2026) & (US$ Million) Table 25. Veterinary Vaccine Industry Trends Table 26. Veterinary Vaccine Industry Drivers Table 27. Veterinary Vaccine Industry Opportunities and Challenges Table 28. Veterinary Vaccine Industry Restraints Table 29. Global Veterinary Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Veterinary Vaccine Revenue Market Share by Company (2021-2026) Table 31. Global Veterinary Vaccine Sales by Company (2021-2026) & (M Doses) Table 32. Global Veterinary Vaccine Sales Share by Company (2021-2026) Table 33. Global Veterinary Vaccine Market Price by Company (2021-2026) & (USD/Doses) Table 34. Global Veterinary Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Veterinary Vaccine Major Company Production Sites and Headquarters Table 36. Global Veterinary Vaccine Company, Product Type & Application Table 37. Global Veterinary Vaccine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Veterinary Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Veterinary Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Veterinary Vaccine Sales by Region (2021-2026) & (M Doses) Table 42. Global Veterinary Vaccine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Veterinary Vaccine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Veterinary Vaccine Sales Market Share in Value by Region (2021-2026) Table 45. Global Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 46. Global Veterinary Vaccine Sales by Region (2027-2032) & (M Doses) Table 47. Global Veterinary Vaccine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Veterinary Vaccine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Veterinary Vaccine Sales Market Share in Value by Region (2027-2032) Table 50. Global Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2027-2032) Table 51. Global Veterinary Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Veterinary Vaccine Sales by Application (2021-2026) & (M Doses) Table 53. Global Veterinary Vaccine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Veterinary Vaccine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Veterinary Vaccine Sales Market Share in Value by Application (2021-2026) Table 56. Global Veterinary Vaccine Price by Application (2021-2026) & (USD/Doses) Table 57. Global Veterinary Vaccine Sales by Application (2027-2032) & (M Doses) Table 58. Global Veterinary Vaccine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Veterinary Vaccine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Veterinary Vaccine Sales Market Share in Value by Application (2027-2032) Table 61. Global Veterinary Vaccine Price by Application (2027-2032) & (USD/Doses) Table 62. North America Veterinary Vaccine Sales by Application (2021-2026) & (M Doses) Table 63. North America Veterinary Vaccine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Veterinary Vaccine Sales by Application (2021-2026) & (M Doses) Table 65. Europe Veterinary Vaccine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Veterinary Vaccine Sales by Application (2021-2026) & (M Doses) Table 67. Asia-Pacific Veterinary Vaccine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Veterinary Vaccine Sales by Application (2021-2026) & (M Doses) Table 69. Latin America Veterinary Vaccine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Veterinary Vaccine Sales by Application (2021-2026) & (M Doses) Table 71. Middle East and Africa Veterinary Vaccine Sales by Application (2021-2026) & (US$ Million) Table 72. Merck Company Information Table 73. Merck Business Overview Table 74. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 75. Merck Veterinary Vaccine Product Portfolio Table 76. Merck Recent Development Table 77. Zoetis Company Information Table 78. Zoetis Business Overview Table 79. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 80. Zoetis Veterinary Vaccine Product Portfolio Table 81. Zoetis Recent Development Table 82. Boehringer Ingelheim Company Information Table 83. Boehringer Ingelheim Business Overview Table 84. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 85. Boehringer Ingelheim Veterinary Vaccine Product Portfolio Table 86. Boehringer Ingelheim Recent Development Table 87. Ceva Company Information Table 88. Ceva Business Overview Table 89. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 90. Ceva Veterinary Vaccine Product Portfolio Table 91. Ceva Recent Development Table 92. CAHIC Company Information Table 93. CAHIC Business Overview Table 94. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 95. CAHIC Veterinary Vaccine Product Portfolio Table 96. CAHIC Recent Development Table 97. HVRI Company Information Table 98. HVRI Business Overview Table 99. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 100. HVRI Veterinary Vaccine Product Portfolio Table 101. HVRI Recent Development Table 102. Ringpu Biology Company Information Table 103. Ringpu Biology Business Overview Table 104. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 105. Ringpu Biology Veterinary Vaccine Product Portfolio Table 106. Ringpu Biology Recent Development Table 107. Yebio Company Information Table 108. Yebio Business Overview Table 109. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 110. Yebio Veterinary Vaccine Product Portfolio Table 111. Yebio Recent Development Table 112. DHN Company Information Table 113. DHN Business Overview Table 114. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 115. DHN Veterinary Vaccine Product Portfolio Table 116. DHN Recent Development Table 117. WINSUN Company Information Table 118. WINSUN Business Overview Table 119. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 120. WINSUN Veterinary Vaccine Product Portfolio Table 121. WINSUN Recent Development Table 122. Elanco Company Information Table 123. Elanco Business Overview Table 124. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 125. Elanco Veterinary Vaccine Product Portfolio Table 126. Elanco Recent Development Table 127. Virbac Company Information Table 128. Virbac Business Overview Table 129. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 130. Virbac Veterinary Vaccine Product Portfolio Table 131. Virbac Recent Development Table 132. Jinyu Bio-Technology Company Information Table 133. Jinyu Bio-Technology Business Overview Table 134. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 135. Jinyu Bio-Technology Veterinary Vaccine Product Portfolio Table 136. Jinyu Bio-Technology Recent Development Table 137. ChengDu Tecbond Company Information Table 138. ChengDu Tecbond Business Overview Table 139. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 140. ChengDu Tecbond Veterinary Vaccine Product Portfolio Table 141. ChengDu Tecbond Recent Development Table 142. CAVAC Company Information Table 143. CAVAC Business Overview Table 144. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 145. CAVAC Veterinary Vaccine Product Portfolio Table 146. CAVAC Recent Development Table 147. Kyoto Biken Laboratories Company Information Table 148. Kyoto Biken Laboratories Business Overview Table 149. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 150. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio Table 151. Kyoto Biken Laboratories Recent Development Table 152. FATRO Company Information Table 153. FATRO Business Overview Table 154. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 155. FATRO Veterinary Vaccine Product Portfolio Table 156. FATRO Recent Development Table 157. Vaksindo Company Information Table 158. Vaksindo Business Overview Table 159. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 160. Vaksindo Veterinary Vaccine Product Portfolio Table 161. Vaksindo Recent Development Table 162. Bio-Labs Company Information Table 163. Bio-Labs Business Overview Table 164. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 165. Bio-Labs Veterinary Vaccine Product Portfolio Table 166. Bio-Labs Recent Development Table 167. Avimex Animal Health Company Information Table 168. Avimex Animal Health Business Overview Table 169. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 170. Avimex Animal Health Veterinary Vaccine Product Portfolio Table 171. Avimex Animal Health Recent Development Table 172. MEVAC Company Information Table 173. MEVAC Business Overview Table 174. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 175. MEVAC Veterinary Vaccine Product Portfolio Table 176. MEVAC Recent Development Table 177. Biovac Company Information Table 178. Biovac Business Overview Table 179. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 180. Biovac Veterinary Vaccine Product Portfolio Table 181. Biovac Recent Development Table 182. Atafen Company Information Table 183. Atafen Business Overview Table 184. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 185. Atafen Veterinary Vaccine Product Portfolio Table 186. Atafen Recent Development Table 187. Dyntec Company Information Table 188. Dyntec Business Overview Table 189. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 190. Dyntec Veterinary Vaccine Product Portfolio Table 191. Dyntec Recent Development Table 192. BioTestLab Company Information Table 193. BioTestLab Business Overview Table 194. BioTestLab Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 195. BioTestLab Veterinary Vaccine Product Portfolio Table 196. BioTestLab Recent Development Table 197. RVSRI Company Information Table 198. RVSRI Business Overview Table 199. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 200. RVSRI Veterinary Vaccine Product Portfolio Table 201. RVSRI Recent Development Table 202. Medion Company Information Table 203. Medion Business Overview Table 204. Medion Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 205. Medion Veterinary Vaccine Product Portfolio Table 206. Medion Recent Development Table 207. North America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 208. North America Veterinary Vaccine Sales by Country (2021-2026) & (M Doses) Table 209. North America Veterinary Vaccine Sales Market Share by Country (2021-2026) Table 210. North America Veterinary Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 211. North America Veterinary Vaccine Sales Market Share Forecast by Country (2027-2032) Table 212. North America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 213. North America Veterinary Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 214. North America Veterinary Vaccine Market Share by Country (2021-2026) Table 215. North America Veterinary Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 216. North America Veterinary Vaccine Market Share Forecast by Country (2027-2032) Table 217. Europe Veterinary Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 218. Europe Veterinary Vaccine Sales by Country (2021-2026) & (M Doses) Table 219. Europe Veterinary Vaccine Sales Market Share by Country (2021-2026) Table 220. Europe Veterinary Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 221. Europe Veterinary Vaccine Sales Market Share Forecast by Country (2027-2032) Table 222. Europe Veterinary Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 223. Europe Veterinary Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 224. Europe Veterinary Vaccine Market Share by Country (2021-2026) Table 225. Europe Veterinary Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 226. Europe Veterinary Vaccine Market Share Forecast by Country (2027-2032) Table 227. Asia-Pacific Veterinary Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 228. Asia-Pacific Veterinary Vaccine Sales by Country (2021-2026) & (M Doses) Table 229. Asia-Pacific Veterinary Vaccine Sales Market Share by Country (2021-2026) Table 230. Asia-Pacific Veterinary Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 231. Asia-Pacific Veterinary Vaccine Sales Market Share Forecast by Country (2027-2032) Table 232. Asia-Pacific Veterinary Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 233. Asia-Pacific Veterinary Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 234. Asia-Pacific Veterinary Vaccine Market Share by Country (2021-2026) Table 235. Asia-Pacific Veterinary Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 236. Asia-Pacific Veterinary Vaccine Market Share Forecast by Country (2027-2032) Table 237. Latin America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 238. Latin America Veterinary Vaccine Sales by Country (2021-2026) & (M Doses) Table 239. Latin America Veterinary Vaccine Sales Market Share by Country (2021-2026) Table 240. Latin America Veterinary Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 241. Latin America Veterinary Vaccine Sales Market Share Forecast by Country (2027-2032) Table 242. Latin America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 243. Latin America Veterinary Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 244. Latin America Veterinary Vaccine Market Share by Country (2021-2026) Table 245. Latin America Veterinary Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 246. Latin America Veterinary Vaccine Market Share Forecast by Country (2027-2032) Table 247. Middle East and Africa Veterinary Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 248. Middle East and Africa Veterinary Vaccine Sales by Country (2021-2026) & (M Doses) Table 249. Middle East and Africa Veterinary Vaccine Sales Market Share by Country (2021-2026) Table 250. Middle East and Africa Veterinary Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 251. Middle East and Africa Veterinary Vaccine Sales Market Share Forecast by Country (2027-2032) Table 252. Middle East and Africa Veterinary Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 253. Middle East and Africa Veterinary Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 254. Middle East and Africa Veterinary Vaccine Market Share by Country (2021-2026) Table 255. Middle East and Africa Veterinary Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 256. Middle East and Africa Veterinary Vaccine Market Share Forecast by Country (2027-2032) Table 257. Key Raw Materials Table 258. Raw Materials Key Suppliers Table 259. Veterinary Vaccine Distributors List Table 260. Veterinary Vaccine Customers List Table 261. Research Programs/Design for This Report Table 262. Authors List of This Report Table 263. Secondary Sources Table 264. Primary Sources List of Figures Figure 1. Veterinary Vaccine Image Figure 2. Global Veterinary Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Vaccine Sales (2021-2032) & (M Doses) Figure 5. Live Attenuated Vaccines Image Figure 6. Global Live Attenuated Vaccines Sales YoY Growth (2021-2032) & (M Doses) Figure 7. Inactivated Vaccines Image Figure 8. Global Inactivated Vaccines Sales YoY Growth (2021-2032) & (M Doses) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (M Doses) Figure 11. Global Veterinary Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Veterinary Vaccine Market Share by Type 2025 VS 2032 Figure 13. North America Veterinary Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. North America Veterinary Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Europe Veterinary Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Veterinary Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Veterinary Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Veterinary Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Veterinary Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Veterinary Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Veterinary Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Veterinary Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Veterinary Vaccine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Livestock Image Figure 26. Global Livestock Sales YoY Growth (2021-2032) & (M Doses) Figure 27. Swine Image Figure 28. Global Swine Sales YoY Growth (2021-2032) & (M Doses) Figure 29. Chicken Image Figure 30. Global Chicken Sales YoY Growth (2021-2032) & (M Doses) Figure 31. Dog & Cat Image Figure 32. Global Dog & Cat Sales YoY Growth (2021-2032) & (M Doses) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (M Doses) Figure 35. Global Veterinary Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Veterinary Vaccine Market Share by Application 2025 VS 2032 Figure 37. North America Veterinary Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. North America Veterinary Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Europe Veterinary Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Europe Veterinary Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Veterinary Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Veterinary Vaccine Sales Market Share in Value by Application in 2025 Figure 43. Latin America Veterinary Vaccine Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Veterinary Vaccine Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Veterinary Vaccine Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Veterinary Vaccine Sales Market Share in Value by Application in 2025 Figure 47. North America Veterinary Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 48. North America Veterinary Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Veterinary Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Veterinary Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Veterinary Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 52. Europe Veterinary Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Veterinary Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Veterinary Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Veterinary Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 56. Asia-Pacific Veterinary Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Veterinary Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Veterinary Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Veterinary Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 60. Latin America Veterinary Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Veterinary Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Veterinary Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Veterinary Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 64. Middle East and Africa Veterinary Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Veterinary Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Veterinary Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Veterinary Vaccine Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Veterinary Vaccine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Others
Applications
  • Livestock
  • Swine
  • Chicken
  • Dog & Cat
  • Others
Companies covered
  • Merck
  • Zoetis
  • Boehringer Ingelheim
  • Ceva
  • CAHIC
  • HVRI
  • Ringpu Biology
  • Yebio
  • DHN
  • WINSUN
  • Elanco
  • Virbac
  • Jinyu Bio-Technology
  • ChengDu Tecbond
  • CAVAC
  • Kyoto Biken Laboratories
  • FATRO
  • Vaksindo
  • Bio-Labs
  • Avimex Animal Health
  • MEVAC
  • Biovac
  • Atafen
  • Dyntec
  • BioTestLab
  • RVSRI
  • Medion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Veterinary Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Veterinary Vaccine Market by Type
  6. 1.3.1 Live Attenuated Vaccines
  7. 1.3.2 Inactivated Vaccines
  8. 1.3.3 Others
  9. 1.4 Global Veterinary Vaccine Market Size by Type
  10. 1.4.1 Global Veterinary Vaccine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Veterinary Vaccine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Veterinary Vaccine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Veterinary Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Veterinary Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Veterinary Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Veterinary Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Veterinary Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Veterinary Vaccine Industry Trends
  2. 2.2 Veterinary Vaccine Industry Drivers
  3. 2.3 Veterinary Vaccine Industry Opportunities and Challenges
  4. 2.4 Veterinary Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Veterinary Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Veterinary Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Veterinary Vaccine Price (2021-2026)
  4. 3.4 Global Veterinary Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Veterinary Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Veterinary Vaccine Company, Product Type & Application
  7. 3.7 Global Veterinary Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Veterinary Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Veterinary Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Veterinary Vaccine Tier 1, Tier 2, and Tier 3
4 Veterinary Vaccine Regional Status and Outlook
  1. 4.1 Global Veterinary Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Veterinary Vaccine Historic Market Size by Region
  3. 4.2.1 Global Veterinary Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Veterinary Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Veterinary Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Veterinary Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Veterinary Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Veterinary Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Veterinary Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Veterinary Vaccine by Application
  1. 5.1 Veterinary Vaccine Market by Application
  2. 5.1.1 Livestock
  3. 5.1.2 Swine
  4. 5.1.3 Chicken
  5. 5.1.4 Dog & Cat
  6. 5.1.5 Others
  7. 5.2 Global Veterinary Vaccine Market Size by Application
  8. 5.2.1 Global Veterinary Vaccine Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Veterinary Vaccine Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Veterinary Vaccine Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Veterinary Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Veterinary Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Veterinary Vaccine Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Veterinary Vaccine Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Veterinary Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Veterinary Vaccine Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Zoetis
  8. 6.2.1 Zoetis Company Information
  9. 6.2.2 Zoetis Business Overview
  10. 6.2.3 Zoetis Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Zoetis Veterinary Vaccine Product Portfolio
  12. 6.2.5 Zoetis Recent Developments
  13. 6.3 Boehringer Ingelheim
  14. 6.3.1 Boehringer Ingelheim Company Information
  15. 6.3.2 Boehringer Ingelheim Business Overview
  16. 6.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boehringer Ingelheim Veterinary Vaccine Product Portfolio
  18. 6.3.5 Boehringer Ingelheim Recent Developments
  19. 6.4 Ceva
  20. 6.4.1 Ceva Company Information
  21. 6.4.2 Ceva Business Overview
  22. 6.4.3 Ceva Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ceva Veterinary Vaccine Product Portfolio
  24. 6.4.5 Ceva Recent Developments
  25. 6.5 CAHIC
  26. 6.5.1 CAHIC Company Information
  27. 6.5.2 CAHIC Business Overview
  28. 6.5.3 CAHIC Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CAHIC Veterinary Vaccine Product Portfolio
  30. 6.5.5 CAHIC Recent Developments
  31. 6.6 HVRI
  32. 6.6.1 HVRI Company Information
  33. 6.6.2 HVRI Business Overview
  34. 6.6.3 HVRI Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 HVRI Veterinary Vaccine Product Portfolio
  36. 6.6.5 HVRI Recent Developments
  37. 6.7 Ringpu Biology
  38. 6.7.1 Ringpu Biology Company Information
  39. 6.7.2 Ringpu Biology Business Overview
  40. 6.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Ringpu Biology Veterinary Vaccine Product Portfolio
  42. 6.7.5 Ringpu Biology Recent Developments
  43. 6.8 Yebio
  44. 6.8.1 Yebio Company Information
  45. 6.8.2 Yebio Business Overview
  46. 6.8.3 Yebio Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Yebio Veterinary Vaccine Product Portfolio
  48. 6.8.5 Yebio Recent Developments
  49. 6.9 DHN
  50. 6.9.1 DHN Company Information
  51. 6.9.2 DHN Business Overview
  52. 6.9.3 DHN Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 DHN Veterinary Vaccine Product Portfolio
  54. 6.9.5 DHN Recent Developments
  55. 6.10 WINSUN
  56. 6.10.1 WINSUN Company Information
  57. 6.10.2 WINSUN Business Overview
  58. 6.10.3 WINSUN Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 WINSUN Veterinary Vaccine Product Portfolio
  60. 6.10.5 WINSUN Recent Developments
  61. 6.11 Elanco
  62. 6.11.1 Elanco Company Information
  63. 6.11.2 Elanco Business Overview
  64. 6.11.3 Elanco Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Elanco Veterinary Vaccine Product Portfolio
  66. 6.11.5 Elanco Recent Developments
  67. 6.12 Virbac
  68. 6.12.1 Virbac Company Information
  69. 6.12.2 Virbac Business Overview
  70. 6.12.3 Virbac Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Virbac Veterinary Vaccine Product Portfolio
  72. 6.12.5 Virbac Recent Developments
  73. 6.13 Jinyu Bio-Technology
  74. 6.13.1 Jinyu Bio-Technology Company Information
  75. 6.13.2 Jinyu Bio-Technology Business Overview
  76. 6.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
  78. 6.13.5 Jinyu Bio-Technology Recent Developments
  79. 6.14 ChengDu Tecbond
  80. 6.14.1 ChengDu Tecbond Company Information
  81. 6.14.2 ChengDu Tecbond Business Overview
  82. 6.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 ChengDu Tecbond Veterinary Vaccine Product Portfolio
  84. 6.14.5 ChengDu Tecbond Recent Developments
  85. 6.15 CAVAC
  86. 6.15.1 CAVAC Company Information
  87. 6.15.2 CAVAC Business Overview
  88. 6.15.3 CAVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 CAVAC Veterinary Vaccine Product Portfolio
  90. 6.15.5 CAVAC Recent Developments
  91. 6.16 Kyoto Biken Laboratories
  92. 6.16.1 Kyoto Biken Laboratories Company Information
  93. 6.16.2 Kyoto Biken Laboratories Business Overview
  94. 6.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
  96. 6.16.5 Kyoto Biken Laboratories Recent Developments
  97. 6.17 FATRO
  98. 6.17.1 FATRO Company Information
  99. 6.17.2 FATRO Business Overview
  100. 6.17.3 FATRO Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 FATRO Veterinary Vaccine Product Portfolio
  102. 6.17.5 FATRO Recent Developments
  103. 6.18 Vaksindo
  104. 6.18.1 Vaksindo Company Information
  105. 6.18.2 Vaksindo Business Overview
  106. 6.18.3 Vaksindo Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Vaksindo Veterinary Vaccine Product Portfolio
  108. 6.18.5 Vaksindo Recent Developments
  109. 6.19 Bio-Labs
  110. 6.19.1 Bio-Labs Company Information
  111. 6.19.2 Bio-Labs Business Overview
  112. 6.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Bio-Labs Veterinary Vaccine Product Portfolio
  114. 6.19.5 Bio-Labs Recent Developments
  115. 6.20 Avimex Animal Health
  116. 6.20.1 Avimex Animal Health Company Information
  117. 6.20.2 Avimex Animal Health Business Overview
  118. 6.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Avimex Animal Health Veterinary Vaccine Product Portfolio
  120. 6.20.5 Avimex Animal Health Recent Developments
  121. 6.21 MEVAC
  122. 6.21.1 MEVAC Company Information
  123. 6.21.2 MEVAC Business Overview
  124. 6.21.3 MEVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 MEVAC Veterinary Vaccine Product Portfolio
  126. 6.21.5 MEVAC Recent Developments
  127. 6.22 Biovac
  128. 6.22.1 Biovac Company Information
  129. 6.22.2 Biovac Business Overview
  130. 6.22.3 Biovac Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Biovac Veterinary Vaccine Product Portfolio
  132. 6.22.5 Biovac Recent Developments
  133. 6.23 Atafen
  134. 6.23.1 Atafen Company Information
  135. 6.23.2 Atafen Business Overview
  136. 6.23.3 Atafen Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Atafen Veterinary Vaccine Product Portfolio
  138. 6.23.5 Atafen Recent Developments
  139. 6.24 Dyntec
  140. 6.24.1 Dyntec Company Information
  141. 6.24.2 Dyntec Business Overview
  142. 6.24.3 Dyntec Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Dyntec Veterinary Vaccine Product Portfolio
  144. 6.24.5 Dyntec Recent Developments
  145. 6.25 BioTestLab
  146. 6.25.1 BioTestLab Company Information
  147. 6.25.2 BioTestLab Business Overview
  148. 6.25.3 BioTestLab Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 BioTestLab Veterinary Vaccine Product Portfolio
  150. 6.25.5 BioTestLab Recent Developments
  151. 6.26 RVSRI
  152. 6.26.1 RVSRI Company Information
  153. 6.26.2 RVSRI Business Overview
  154. 6.26.3 RVSRI Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 RVSRI Veterinary Vaccine Product Portfolio
  156. 6.26.5 RVSRI Recent Developments
  157. 6.27 Medion
  158. 6.27.1 Medion Company Information
  159. 6.27.2 Medion Business Overview
  160. 6.27.3 Medion Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
  161. 6.27.4 Medion Veterinary Vaccine Product Portfolio
  162. 6.27.5 Medion Recent Developments
7 North America by Country
  1. 7.1 North America Veterinary Vaccine Sales by Country
  2. 7.1.1 North America Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Veterinary Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Veterinary Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Veterinary Vaccine Market Size by Country
  6. 7.2.1 North America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Veterinary Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Veterinary Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Veterinary Vaccine Sales by Country
  2. 8.1.1 Europe Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Veterinary Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Veterinary Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Veterinary Vaccine Market Size by Country
  6. 8.2.1 Europe Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Veterinary Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Veterinary Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Veterinary Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Veterinary Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Veterinary Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Veterinary Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Veterinary Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Veterinary Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Veterinary Vaccine Sales by Country
  2. 10.1.1 South America Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Veterinary Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Veterinary Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Veterinary Vaccine Market Size by Country
  6. 10.2.1 South America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Veterinary Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Veterinary Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Veterinary Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Veterinary Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Veterinary Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Veterinary Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Veterinary Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Veterinary Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Veterinary Vaccine Value Chain Analysis
  2. 12.1.1 Veterinary Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Veterinary Vaccine Production Mode & Process
  7. 12.2 Veterinary Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Veterinary Vaccine Distributors
  10. 12.2.3 Veterinary Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst